SCHEMBL23766637

SCHEMBL23766637

CC(C)=NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPI P09923 1/20 0.53
PKM P14618 1/20 0.53
PTGS1 P23219 1/20 0.53
XIAP P98170 1/20 0.53
SLC7A5 Q01650 1/20 0.53
CYP1A2 P05177 1/20 0.52
POLB P06746 2/20 0.47
ALPL P05186 1/20 0.47
ALPG P10696 1/20 0.47
CPA3 P15088 3/20 0.46
CPA1 P15085 2/20 0.46
FOLH1 Q04609 1/20 0.46
CPB1 P15086 1/20 0.46
CPB2 Q96IY4 1/20 0.46
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
HSD17B10 Q99714 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1193057 0.80 PPARG (0.50) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL2118063 0.80 PPARG (0.50) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL3740070 0.79 ALPI (0.44) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL3740060 0.79 ALPI (0.44) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL4655391 0.79 CYP1A2 (0.57) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL8201005 0.79 CYP1A2 (0.57) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL6256923 0.79 CYP1A2 (0.57) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL17234575 0.77 ALPI (0.49) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL7449663 0.77 CYP1A2 (0.55) ALPIPKMPTGS1XIAPSLC7A5
SCHEMBL7449656 0.77 CYP1A2 (0.55) ALPIPKMPTGS1XIAPSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-28 US disclosed
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-28 US disclosed
US-20210253517-A1 METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253517-A1 METHOD FOR PRODUCING AMINO ACID AMINOALKYL ESTER OR INORGANIC ACID SALT THEREOF SLC6A15, SLC6A19, ALAD ALPI 700/4885PKM 1259/4885PTGS1 2743/4885
US-11827586-B2 Method for producing amino acid aminoalkyl ester or inorganic acid salt thereof SLC6A15, SLC6A19, ALAD ALPI 700/4885PKM 1259/4885PTGS1 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.